Methods and systems for presenting an inhalation experience

• US 20100166613A1
• Filed: 02/20/2009
• Published: 07/01/2010
• Est. Priority Date: 12/30/2008
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Tegreene, Clarence T., Langer, Robert, Lord, Robert W., Wood, Lowell L. JR., Hyde, Roderick A., Sweeney, Elizabeth A., Leuthardt, Eric C.
• Application Number:
  US12/380,013
• Publication Number:
  US 20100166613A1
• Time in Patent Office: Days
• US Class Current: 422/84
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/02 Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/11 Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb for measuring pulse A61B5/02 ;A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/165 Evaluating the state of mind, e.g. depression, anxiety
• CPC Class Codes: A61B 5/377 using evoked responses
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/486 Bio-feedback A61B5/375 takes precedence
• CPC Class Codes: A61B 5/6822 Neck
• CPC Class Codes: A61M 11/00 Sprayers or atomisers specially adapted for therapeutic purposes in general B05B; aerosol containers B65D83/14
• CPC Class Codes: A61M 15/00 Inhalators drug delivery in endotracheal tubes A61M16/04
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 15/0065 Inhalators with dosage or measuring devices A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 15/02 with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
• CPC Class Codes: A61M 15/08 Inhaling devices inserted into the nose
• CPC Class Codes: A61M 2021/0016 : by the smell sense
• CPC Class Codes: A61M 2205/3553 : remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3569 : sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/3584 : using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/3592 : using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2205/50 : with microprocessors or computers
• CPC Class Codes: A61M 2205/581 : by audible feedback
• CPC Class Codes: A61M 2205/582 : by tactile feedback
• CPC Class Codes: A61M 2205/583 : by visual feedback
• CPC Class Codes: A61M 2205/588 : by olfactory feedback, i.e. smell
• CPC Class Codes: A61M 2209/088 : on the body
• CPC Class Codes: A61M 2230/201 : Glucose concentration
• CPC Class Codes: A61M 2230/205 : partial oxygen pressure (P-O2)
• CPC Class Codes: A63F 2300/65 : for computing the condition of a game character
• CPC Class Codes: A63F 2300/6692 : using special effects, generally involving post-processing, e.g. blooming
• CPC Class Codes: G16H 20/13 : delivered from dispensers

Abstract

Methods, computer program products, and systems are described that include detecting in an exhalant at least one indication of bioactive agent use by an individual and altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual.

Claims

1. A system, comprising:

means for detecting in an exhalant at least one indication of bioactive agent use by an individual; and

means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual.

2. The system of claim 1 wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting with an exhaled breath analysis device at least one indication of bioactive agent use by an individual.

3. The system of claim 2 wherein the means for detecting with an exhaled breath analysis device at least one indication of bioactive agent use by an individual comprises:

means for detecting with a wireless exhaled breath analysis device at least one indication of bioactive agent use by an individual.

4. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting with a bioactive agent-dispensing inhalation collar at least one indication of bioactive agent use by an individual.

5. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting with a medication-dispensing inhalation device an indication of bioactive agent use by an individual.

7. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting an indication of at least one of a steroid, an anti-inflammatory, a bronchodilator, an expectorant, menthol, nitrous oxide, a CNS depressant, an anti-allergic agent, a muscle relaxant, or anesthetic.

8. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting an indication of an unregulated bioactive agent.

10. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting an indication of a recreational bioactive agent.

12. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting with an exhaled breath analysis device having a transducer at least one indication of bioactive agent use by an individual.

13. The system of claim 1, wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual comprises:

means for detecting with an exhaled breath analysis device having an alcohol detector at least one indication of bioactive agent use by an individual.

14. The system of claim 1, wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering access to at least a portion of the at least one artificial sensory experience.

17. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering a scene in an artificial sensory experience.

20. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering a sound in an artificial sensory experience.

24. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering an artificial sensory experience to enhance the efficacy of the bioactive agent.

25. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering an artificial sensory experience to reduce a side effect of the bioactive agent.

26. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for adding at least one of visual, tactile, or audio content to the artificial sensory experience.

27. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for deleting at least one of visual or audio content of the artificial sensory experience.

28. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for adding content to the artificial sensory experience and deleting different content from the artificial sensory experience.

29. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering a sensate experience to modify the at least one effect of the bioactive agent.

31. The system of claim 1 wherein the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprises:

means for altering an artificial sensory experience implemented on a mobile device.

32. The system of claim 1 wherein the means for detecting in an exhalant at least one indication of bioactive agent use by an individual and the means for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual comprise:

means for detecting with an inhalation collar an indication of albuterol use by an individual with asthma and altering a virtual world to display a mountainous environment configured to teach a deep breathing technique.

6. (canceled)

9. (canceled)

11. (canceled)

15-16. -16. (canceled)

18-19. -19. (canceled)

21-23. -23. (canceled)

30. (canceled)

33. A computer-implemented method, comprising:

detecting in an exhalant at least one indication of bioactive agent use by an individual; and

altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual.

34-64. -64. (canceled)

65. A system, comprising:

circuitry for detecting in an exhalant at least one indication of bioactive agent use by an individual; and

circuitry for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual.

66. A computer program product comprising:

a signal-bearing medium bearing

one or more instructions for detecting in an exhalant at least one indication of bioactive agent use by an individual; and

one or more instructions for altering at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual.

67. The computer program product of claim 66, wherein the signal-bearing medium includes a computer-readable medium.

68. The computer program product of claim 66, wherein the signal-bearing medium includes a recordable medium.

69. The computer program product of claim 66, wherein the signal-bearing medium includes a communications medium.

70. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

detect in an exhalant at least one indication of bioactive agent use by an individual; and

alter at least one artificial sensory experience at least partly based on the at least one indication of bioactive agent use by an individual.

71. The system of claim 70 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

72. The system of claim 70, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.